28058834|t|pH -Dependent Transmembrane Activity of Peptide -Functionalized Gold Nanostars for Computed Tomography / Photoacoustic Imaging and Photothermal Therapy
28058834|a|Progress in multifunctional nanomaterials for tumor therapy mostly depends on the development of tumor - targeting delivery strategies. One approach is to explore a pH -responsive strategy to target the slightly acidic solid tumor microenvironment. A novel class of pH (low) insertion peptides (pHLIPs) with pH -dependent transmembrane activity can fold and rapidly insert into the lipid bilayer of tumor cells triggered by acidity, facilitating the cellular internalization of nanomaterials synchronously. Here, we innovatively decorated gold nanostars (GNSs) with pHLIPs (GNS - pHLIP) to improve their targeting ability and photothermal therapeutic (PTT) efficiency. The obtained GNS - pHLIP exhibited the excellent characteristics of uniform size and good biocompatibility. As compared to GNS - mPEG, the cellular internalization of GNS - pHLIP was 1-fold higher after a 2 h incubation with cells in media at pH 6.4 than at pH 7.4. Moreover, the tumor accumulation of the GNS - pHLIP was 3-fold higher than that of GNS - mPEG after intravenous injection into MCF-7 breast tumor animal models for 24 h. Furthermore, GNS - pHLIP exhibited stronger signals than the GNS - mPEG through computed tomography (CT) and photoacoustic (PA) imaging. Simultaneously, the desirable targeting efficiency significantly improved the PTT efficacy to tumors, with low side effects on normal tissues. The results clearly demonstrate that the GNS - pHLIP successfully took advantage of the tumor - targeting ability of pHLIPs and the good characteristics of GNS s, which may contribute to the study of tumor imaging and therapy.
28058834	0	2	pH	T081	C0020283
28058834	14	36	Transmembrane Activity	T044	C1148560
28058834	40	47	Peptide	T116	C0030956
28058834	64	78	Gold Nanostars	T121,T196	C0018026
28058834	83	102	Computed Tomography	T060	C0040405
28058834	105	126	Photoacoustic Imaging	T060	C3897929
28058834	131	151	Photothermal Therapy	T061	C0454527
28058834	152	160	Progress	T169	C1280477
28058834	164	193	multifunctional nanomaterials	T073	C1450053
28058834	198	211	tumor therapy	T061	C0920425
28058834	234	245	development	T169	C1527148
28058834	249	254	tumor	T191	C0027651
28058834	257	266	targeting	T169	C1521840
28058834	267	286	delivery strategies	T061	C0087111
28058834	292	300	approach	T169	C1292724
28058834	317	319	pH	T081	C0020283
28058834	332	340	strategy	T169	C0449851
28058834	344	350	target	T169	C1521840
28058834	364	399	acidic solid tumor microenvironment	T070	C2936626
28058834	418	445	pH (low) insertion peptides	T116,T123	C2606266
28058834	447	453	pHLIPs	T116,T123	C2606266
28058834	460	462	pH	T081	C0020283
28058834	474	496	transmembrane activity	T044	C1148560
28058834	501	505	fold	T082	C0332462
28058834	518	524	insert	T169	C0205245
28058834	534	547	lipid bilayer	T026	C0023768
28058834	551	562	tumor cells	T025	C0597032
28058834	576	583	acidity	T070	C1254365
28058834	602	626	cellular internalization	T067	C1254366
28058834	630	643	nanomaterials	T073	C1450053
28058834	644	657	synchronously	T079	C0439580
28058834	691	705	gold nanostars	T121,T196	C0018026
28058834	707	711	GNSs	T121,T196	C0018026
28058834	718	724	pHLIPs	T116,T123	C2606266
28058834	726	729	GNS	T121,T196	C0018026
28058834	732	737	pHLIP	T116,T123	C2606266
28058834	756	765	targeting	T169	C1521840
28058834	778	802	photothermal therapeutic	T061	C0454527
28058834	804	807	PTT	T061	C0454527
28058834	809	819	efficiency	T081	C0013682
28058834	834	837	GNS	T121,T196	C0018026
28058834	840	845	pHLIP	T116,T123	C2606266
28058834	870	885	characteristics	T080	C1521970
28058834	897	901	size	T082	C0456389
28058834	911	927	biocompatibility	T044	C0596177
28058834	944	947	GNS	T121,T196	C0018026
28058834	950	954	mPEG	T109	C0066763
28058834	960	984	cellular internalization	T067	C1254366
28058834	988	991	GNS	T121,T196	C0018026
28058834	994	999	pHLIP	T116,T123	C2606266
28058834	1046	1051	cells	T025	C0007634
28058834	1055	1060	media	T167	C1705217
28058834	1064	1066	pH	T081	C0020283
28058834	1079	1081	pH	T081	C0020283
28058834	1101	1106	tumor	T191	C0027651
28058834	1107	1119	accumulation	T033	C4055506
28058834	1127	1130	GNS	T121,T196	C0018026
28058834	1133	1138	pHLIP	T116,T123	C2606266
28058834	1170	1173	GNS	T121,T196	C0018026
28058834	1176	1180	mPEG	T109	C0066763
28058834	1187	1208	intravenous injection	T169	C0021494
28058834	1214	1219	MCF-7	T025	C0596890
28058834	1220	1232	breast tumor	T191	C1458155
28058834	1233	1246	animal models	T050	C0012644
28058834	1270	1273	GNS	T121,T196	C0018026
28058834	1276	1281	pHLIP	T116,T123	C2606266
28058834	1301	1308	signals	T067	C1710082
28058834	1318	1321	GNS	T121,T196	C0018026
28058834	1324	1328	mPEG	T109	C0066763
28058834	1337	1356	computed tomography	T060	C0040405
28058834	1358	1360	CT	T060	C0040405
28058834	1366	1392	photoacoustic (PA) imaging	T060	C3897929
28058834	1424	1433	targeting	T169	C1521840
28058834	1434	1444	efficiency	T081	C0013682
28058834	1472	1475	PTT	T061	C0454527
28058834	1476	1484	efficacy	T080	C1280519
28058834	1488	1494	tumors	T191	C0027651
28058834	1505	1517	side effects	T046	C0879626
28058834	1528	1535	tissues	T024	C0040300
28058834	1578	1581	GNS	T121,T196	C0018026
28058834	1584	1589	pHLIP	T116,T123	C2606266
28058834	1625	1630	tumor	T191	C0027651
28058834	1633	1642	targeting	T169	C1521840
28058834	1654	1660	pHLIPs	T116,T123	C2606266
28058834	1674	1689	characteristics	T080	C1521970
28058834	1693	1696	GNS	T121,T196	C0018026
28058834	1693	1698	GNS s	T121,T196	C0018026
28058834	1737	1742	tumor	T191	C0027651
28058834	1743	1750	imaging	T060	C0011923
28058834	1755	1762	therapy	T061	C0087111